Omez, 20 mg capsules 30 pcs

Name: Omez, 20 mg capsules 30 pcs
SKU: 28011
Availability: InStock

€5.06

EAN: 8901148060012 SKU: 28011 Categories: Medicine, Stomach, intestines, liver, Ulcer and gastritis

Gastric and duodenal ulcer, GI infections caused by Helicobacter pylori, reflux esophagitis, Heartburn, Pain in the epigastric region, Acid reflux, Nausea Adults
Gastric and duodenal ulcer (including relapse prevention).
Gastroesophageal reflux disease (GERD).
Hypersecretory conditions (Zollinger-Ellison syndrome, stress ulcers of the gastrointestinal tract, polyendocrine adenomatosis, systemic mastocytosis).
Eradication of Helicobacter pylori in infected patients with peptic ulcer disease of the stomach and duodenum (in combination therapy).

Prevention and treatment of damages of mucous coat of the stomach and duodenum caused by taking non-steroidal anti-inflammatory drugs (NSAID-gastropathy): dyspepsia, erosions of the mucous coat, peptic ulcer.
Prevention of Mendelsohn syndrome (aspiration pneumonitis).

Children
Over 2 years of age and body weight over 20 kg: in therapy of gastroesophageal reflux disease;
Over 4 years of age and body weight over 20 kg: in therapy of duodenal ulcer caused by Helicobacter pylori.
Safety and efficacy in other indications in pediatric patients have not been established.

Active ingredient

Omeprazole

How to take, the dosage

Orally, with plenty of water (the contents of the capsule should not be chewed), 30 minutes before a meal.
If the patient cannot swallow the whole capsule, you can mix its contents with lightly acidified liquid, juice or fruit puree. DO NOT dissolve in carbonated beverages or milk. The resulting mixture should be consumed internally immediately after preparation.

Adults

In case of gastric and duodenal ulcer (including relapse prevention) – 20 mg 1 time per day; Patients who are resistant to treatment with other anti-ulcer drugs are prescribed in a dose of 40 mg daily, the course of treatment for duodenal ulcer is 2 weeks, if necessary – up to 4 weeks; for peptic ulcer – 4-8 weeks.

Interaction

Can decrease absorption of ampicillin esters, iron salts, itraconazole and ketoconazole (omeprazole increases gastric pH).

Special Instructions

In the presence of any alarming symptoms, such as significant spontaneous weight loss, frequent vomiting, dysphagia, vomiting with blood or melena, and in the presence of gastric ulcer (or suspected gastric ulcer) the possibility of malignancy should be excluded, since treatment with Omez® may result in alleviation of symptoms and delay diagnosis.
Decreased secretion of hydrochloric acid in the stomach under the action of proton pump inhibitors leads to increased growth of normal intestinal microflora and may lead to a slight increase in the risk of intestinal infections caused by bacteria of the genus Salmonella spp, Campylobacter spp. and Clostridium difficile bacteria.

Decreased acidity against the background of omeprazole administration may also lead to decreased absorption of vitamin B12 (cyanocobalamin).
With concomitant use of omeprazole with clopidogrel there is a decrease in the antiaggregant effect of the latter.
Patients at risk of osteoporosis or osteoporotic fractures should be under appropriate clinical observation, although a causal association of omeprazole/esomeprazole with osteoporotic fractures has not been established.

There have been reports of severe hypomagnesemia in patients receiving therapy with proton pump inhibitors, including omeprazole, for more than one year. Patients receiving therapy with omeprazole for a long time, especially in combination with digoxin or other drugs that reduce magnesium content in blood plasma (diuretics), require regular monitoring of magnesium.
Effect on laboratory tests

Decreased levels of hydrochloric acid secretion may lead to increased concentration of chromogranin A (CgA), which affects the results of examinations to detect neuroendocrine tumors. To prevent this effect, therapy with proton pump inhibitors should be stopped 5 days before the CgA concentration study.

Synopsis

Solid gelatin transparent capsules size “2” with colorless body, pink cap and black “OMEZ” markings on both parts of the capsule.

Contraindications

Hypersensitivity to omeprazole, substituted benzimidazoles or other drug components.

Side effects

The incidence of adverse drug reactions is stated according to the following grading: very common (>1/10); common (≥1/100, <1/10); infrequent (≥1/1000, <1/100); rare (≥1/10000, <1/1000); very rare (<1/10000, including isolated cases).

Overdose

Symptoms: confusion, blurred vision, drowsiness, dry mouth, headache, nausea, tachycardia, arrhythmia.

Treatment: symptomatic. Hemodialysis is not sufficiently effective.

Pregnancy use

Studies have shown no adverse effects of omeprazole on the health of pregnant women, on the fetus, or on the newborn.

Similarities

Omez, Omisak, Gastrozol, Losek MAPS, Ultop, Ortanol, Omitox, Omeprazol, Omeprazol-Teva

Additional information

Weight	0.036 kg
Shelf life	3 years
Conditions of storage	At the temperature not more than 25 ° C. Keep out of reach of children!
Manufacturer	Dr. Reddy's, India
Medication form	capsules
Brand	Dr. Reddy's